Outcome of Board Meeting held on May 26, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
HCP Plastene Bulkpack's board approved audited standalone and consolidated financial results for FY25 (ended March 31, 2025), accompanied by an unqualified (unmodified) auditor's opinion from M/s Ashok Dhariwal & Co. On a standalone basis, revenue jumped to Rs 11,808.53 lakhs from Rs 4,554.91 lakhs in FY24, and the company swung to a profit of Rs 574.37 lakhs from a loss of Rs 276.37 lakhs. On a consolidated basis, revenue rose to Rs 46,343.54 lakhs (vs Rs 29,455.55 lakhs) with profit after tax climbing to Rs 1,332.91 lakhs (vs Rs 30.81 lakhs). The board also approved disinvestment in its Malaysian subsidiary, ratified the launch of a new business unit (Unit 4) effective April 1, 2025, approved a new internal auditor (BDO India LLP) and secretarial auditor, and cleared increasing investment up to 70% in Saeed Ghodran Group, Saudi Arabia.
The sharp revenue growth and turnaround to profit on both standalone and consolidated levels are clearly positive for shareholders, suggesting strong business momentum. However, operating cash flows remained deeply negative (standalone OCF of Rs -1,274 lakhs, consolidated OCF of Rs -1,844 lakhs), which is a watchpoint despite the headline profit. Strategic actions like the new unit, Saudi investment increase, and Malaysian subsidiary exit may reshape the business mix going forward.